Britt Meelby Jensen, a former executive at Novo Nordisk A/S, has been appointed chief executive officer of Zealand Pharma A/S effective 15 January 2015. She will take over this position from David Solomon who has been CEO since 2008. Ms Jensen was most recently CEO of Dako Denmark A/S, a cancer diagnostics company acquired by Agilent Technologies Inc in 2012.
Zealand Pharma announced the appointment on 7 November 2014.|
Copyright 2014 Evernow Publishing Ltd